跳至主要内容
临床试验/NCT01815437
NCT01815437已完成不适用

Evaluation of Vitamin D in a Mushroom Supplement

Boston University1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2012年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
80
试验地点
1
主要终点
Changes in total 25(OH)D in mushroom supplement or crystalline supplement

研究概览

简要总结

This study will evaluate how much vitamin D is present in a mushroom supplement. This supplement contains an extract from mushrooms that have been exposed to sunlight. The mushroom supplement will be compared to non-commercially available vitamin D supplements produced in a Goo Manufacturing Practices (GMP)-licensed facility.

详细描述

Mushrooms have the capability to produce vitamin D in a similar way to human skin. When exposed to ultraviolet light, mushrooms will convert a precursor to vitamin D. This reaction produces large amounts of vitamin D. This study is comparing a natural source of vitamin D to a synthetic source of vitamin D and will help determine if mushrooms are a novel source for this essential nutrient.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •All healthy adults, male and female, age 18-64 years

排除标准

  • •Currently taking, or having taken less than one month prior to start of study, a prescription of 50,000 IU of vitamin D2 or 2000 IU vitamin D2 or vitamin D3
  • •Allergy to mushrooms
  • •History of elevated calcium (>10.4 mg%)
  • •Patients with a current or recent history of severe, progressive, and/or uncontrolled renal, hepatic, hematological, endocrine, pulmonary, cardiac, neurological, or cerebral disease.
  • •Supplementation with over the counter formulations of vitamin D2 or vitamin D3
  • •Subjects with a history of an adverse reaction to orally administered vitamin D.
  • •Subjects who are taking oral Dilantin or glucocorticoids.
  • •Exposure to a tanning bed or tanning on a beach for more than eight hours with no sunscreen within 2 weeks prior to start of study.
  • •History of intestinal malabsorption (i.e. cystic fibrosis, fat malabsorption syndrome, Crohn's Disease, gastric bypass surgery).
  • •Subjects with any other condition which in the Investigator's judgment would make the patient unsuitable for inclusion in the study.

研究组 & 干预措施

2000 IU Vitamin D2- Ergocalciferol

Active Comparator

Take 2000 IU crystalline vitamin D2 supplement once/day for 12 weeks.

干预措施: Vitamin D2 - Ergocalciferol (Dietary Supplement)

2000 IU Mushroom Vitamin D2

Experimental

Take 2000 IU vitamin D2 in a mushroom supplement once/day for 12 weeks

干预措施: Mushroom Vitamin D2 (Dietary Supplement)

Mushroom Extract

Placebo Comparator

Capsules with mushroom extract and no vitamin D. The intervention is mushroom extract.

干预措施: Mushroom Extract (Dietary Supplement)

2000 IU Vitamin D3- Cholecalciferol

Active Comparator

Take 2000 IU crystalline vitamin D3 once/day for 12 weeks.

干预措施: Cholecalciferol (Dietary Supplement)

结局指标

主要结局

Changes in total 25(OH)D in mushroom supplement or crystalline supplement

时间窗: 12 weeks

The primary outcome of this study is to examine changes in total 25(OH)D levels after ingestion of a vitamin D2 mushroom supplement manufactured by Monterey Mushrooms, Inc. compared to crystalline vitamin D2 from Nature's Life or vitamin D3 manufactured by Whole Health, Inc.

次要结局

  • Changes in gene expression due to mushroom supplement or crystalline supplement(12 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验